Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Ivermectin, antibacterial drugs, and beta-glucan successfully treated a police dog's demodicosis.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

Thunbergia grandiflora and Russelia equisetiformis help each other grow by changing their shapes.

Tea tree oil may help treat scalp alopecia by promoting hair follicle stem cell growth.

Psychological factors can cause hair and scalp problems.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The new AI system improves remote skin condition diagnosis and access to care.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

The document's conclusion cannot be provided because the content is not accessible.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

IRS premature desquamation is not unique to CCCA and occurs in various scarring alopecias.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The new biodegradable nanocarriers safely and effectively deliver drugs into the skin.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

The document's conclusion cannot be provided because the document is not readable or understandable.